Unknown

Dataset Information

0

Nuclease digestion and mass spectrometric characterization of oligodeoxyribonucleotides containing 1,2-GpG, 1,2-ApG, and 1,3-GpXpG cisplatin intrastrand cross-links.


ABSTRACT: The primary mode of action for cis-diamminedichloroplatinum (II), referred to as cisplatin, toward the treatment of solid malignancies is through formation of cross-links with DNA at purine sites, especially guanines.We prepared oligodeoxyribonucleotides (ODNs) containing a 1,2-GpG, 1,2-ApG, or 1,3-GpXpG cisplatin intrastrand cross-link and the corresponding ODNs modified with (15)N2-labeled cisplatin, and characterized these ODNs with electrospray ionization mass spectrometry (ESI-MS) and tandem MS (MS/MS). We also employed LC-MS/MS to characterize the digestion products of these ODNs after treatment with a cocktail of 4 enzymes (nuclease P1, phosphodiesterases I and II, and alkaline phosphatase).1,2-GpG was released from the ODNs as a dinucleoside monophosphate or a dinucleotide. Analyses of the digestion products of ODNs containing a 1,2-GpG cross-link on the 5' or 3' terminus revealed that the dinucleotide carries a terminal 5' phosphate. On the other hand, digestion of the 1,3-GpXpG intrastrand cross-link yielded 3 dinucleoside products with 0, 1, or 2 phosphate groups.The availability of the ODNs carrying the stable isotope-labeled lesions, MS/MS analyses of the cisplatin-modified ODNs, and the characterization of the enzymatic digestion products of these ODNs set the stage for the future LC-MS/MS quantification of the 1,2-GpG, 1,2-ApG, and 1,3-GpXpG lesions in cellular DNA.

SUBMITTER: Williams RT 

PROVIDER: S-EPMC3625460 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nuclease digestion and mass spectrometric characterization of oligodeoxyribonucleotides containing 1,2-GpG, 1,2-ApG, and 1,3-GpXpG cisplatin intrastrand cross-links.

Williams Renee T RT   Nalbandian Jenifer N JN   Tu Audrey A   Wang Yinsheng Y  

Clinica chimica acta; international journal of clinical chemistry 20121222


<h4>Background</h4>The primary mode of action for cis-diamminedichloroplatinum (II), referred to as cisplatin, toward the treatment of solid malignancies is through formation of cross-links with DNA at purine sites, especially guanines.<h4>Methods</h4>We prepared oligodeoxyribonucleotides (ODNs) containing a 1,2-GpG, 1,2-ApG, or 1,3-GpXpG cisplatin intrastrand cross-link and the corresponding ODNs modified with (15)N2-labeled cisplatin, and characterized these ODNs with electrospray ionization m  ...[more]

Similar Datasets

| S-EPMC3154474 | biostudies-literature
| S-EPMC113142 | biostudies-literature
| S-EPMC2495024 | biostudies-literature
| S-EPMC1065259 | biostudies-literature
| S-EPMC137981 | biostudies-literature
| S-EPMC2533692 | biostudies-literature
| S-EPMC2567932 | biostudies-literature
| S-EPMC2129171 | biostudies-literature
| S-EPMC3051461 | biostudies-literature
| S-EPMC3012088 | biostudies-literature